Paradigm Biocapital Advisors as of June 30, 2024
Portfolio Holdings for Paradigm Biocapital Advisors
Paradigm Biocapital Advisors holds 35 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nuvalent Inc-a (NUVL) | 13.3 | $347M | 4.6M | 75.86 | |
| Argenx Se Sponsored Adr (ARGX) | 8.9 | $231M | 538k | 430.04 | |
| Arcellx Common Stock (ACLX) | 8.1 | $212M | 3.8M | 55.19 | |
| Revolution Medicines (RVMD) | 7.8 | $204M | 5.3M | 38.81 | |
| Sarepta Therapeutics (SRPT) | 5.7 | $150M | 948k | 158.00 | |
| Disc Medicine (IRON) | 4.7 | $122M | 2.7M | 45.07 | |
| Merus N V (MRUS) | 4.6 | $120M | 2.0M | 59.17 | |
| Crinetics Pharmaceuticals In (CRNX) | 4.3 | $113M | 2.5M | 44.79 | |
| Cerevel Therapeutics Hldng I (CERE) | 3.6 | $95M | 2.3M | 40.89 | |
| Kura Oncology (KURA) | 3.6 | $94M | 4.5M | 20.59 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.5 | $91M | 664k | 136.38 | |
| Olema Pharmaceuticals (OLMA) | 3.3 | $86M | 7.9M | 10.82 | |
| Xenon Pharmaceuticals (XENE) | 3.0 | $80M | 2.0M | 38.99 | |
| Tarsus Pharmaceuticals (TARS) | 2.5 | $66M | 2.4M | 27.18 | |
| Janux Therapeutics (JANX) | 2.5 | $66M | 1.6M | 41.89 | |
| Arvinas Ord (ARVN) | 2.5 | $65M | 2.4M | 26.62 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 2.0 | $53M | 1.2M | 44.29 | |
| Vaxcyte (PCVX) | 1.8 | $47M | 627k | 75.51 | |
| Y Mabs Therapeutics | 1.8 | $47M | 3.9M | 12.08 | |
| Edgewise Therapeutics (EWTX) | 1.6 | $42M | 2.3M | 18.01 | |
| Immatics SHS (IMTX) | 1.5 | $40M | 3.4M | 11.62 | |
| Miragen Therapeutics (VRDN) | 1.4 | $38M | 2.9M | 13.01 | |
| Immunovant (IMVT) | 1.4 | $36M | 1.4M | 26.40 | |
| Cogent Biosciences (COGT) | 1.2 | $31M | 3.6M | 8.43 | |
| Bridgebio Pharma (BBIO) | 1.1 | $28M | 1.1M | 25.33 | |
| Cullinan Oncology (CGEM) | 1.0 | $27M | 1.5M | 17.44 | |
| Erasca (ERAS) | 0.7 | $17M | 7.3M | 2.36 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.5 | $14M | 2.3M | 6.04 | |
| Apogee Therapeutics (APGE) | 0.5 | $13M | 330k | 39.35 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.4 | $10M | 721k | 14.46 | |
| Alx Oncology Hldgs (ALXO) | 0.4 | $9.5M | 1.6M | 6.03 | |
| Perspective Therapeutics Com New (CATX) | 0.4 | $9.2M | 920k | 9.97 | |
| Vor Biopharma (VOR) | 0.2 | $6.5M | 6.5M | 1.00 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.1 | $3.8M | 660k | 5.80 | |
| Tscan Therapeutics (TCRX) | 0.1 | $2.1M | 354k | 5.85 |
